Table 1.
Baseline demographics and prior treatment of enrolled patients
| Total (N = 15) | |
|---|---|
| Age (years) | |
| Median (range) | 58 (40–73) |
| Height (cm) | |
| Mean SD | 163.0 ± 7.13 |
| Weight (kg) | |
| Mean SD | 64.0 ± 8.50 |
| Body surface area (m2) | |
| Mean SD | 1.642 ± 0.132 |
| Gender, n (%) | |
| Male | 9 (60.0) |
| Female | 6 (40.0) |
| ECOG performance status, n (%) | |
| 0 | 4 (26.7) |
| 1 | 11 (73.3) |
| Tumor type, n (%) | |
| NSCLC | 3 (20.0) |
| Breast | 2 (13.3) |
| Colorectal | 3 (20.0) |
| Biliary | 2 (13.3) |
| Othera | 5 (33.3) |
| Previous treatment, n (%) | |
| Surgery | 13 (86.7) |
| Radiation | 9 (60.0) |
| Chemotherapy | 15 (100.0) |
| Prior chemotherapy regimens, n (%) | |
| Platinum | 9 (60.0) |
| Taxane | 7 (46.7) |
| Anthracycline | 6 (40.0) |
| No. of prior chemotherapy regimens, n (%) | |
| 1 | 2 (13.3) |
| 2 | 2 (13.3) |
| 3 | 2 (13.3) |
| 4 | 3 (20.0) |
| ≥5 | 6 (40.0) |
| Median (range) | 4.0 (1–7) |
aOther tumor types include cervical, head and neck, liposarcoma, melanoma, and renal